Representatives of the nurses who are inside the hospital have alleged that the hospital did not take enough precautions while handling the...

"With the new facility in the Middle East, we aim to focus on our commitment to developing NCEs to fight the health issues," Wockhardt Foun...

Sell Wockhardt Ltd. at a price target of Rs 705.0 and a stop loss at Rs 741 from entry point.

Buy Wockhardt Ltd. at a price target of Rs 880.0 and a stop loss at Rs 800 from entry point.

Buy Wockhardt Ltd. at a price target of Rs 840.0 and a stop loss at Rs 810 from entry point.

Buy Wockhardt Ltd. at a price target of Rs 795.0 and a stop loss at Rs 750 from entry point.

Buy Wockhardt Ltd. at a price target of Rs 985.0 and a stop loss at Rs 940 from entry point.

Buy Wockhardt Ltd. at a price target of Rs 850.0 and a stop loss at Rs 795 from entry point.

Buy Wockhardt Ltd. at a price target of Rs 800.0 and a stop loss at Rs 775 from entry point.

Buy Wockhardt Ltd. at a price target of Rs 775.0 and a stop loss at Rs 750 from entry point.

Buy Wockhardt at a price target of Rs 825.0 and a stop loss at Rs 725 from entry point.

Buy Wockhardt at a price target of Rs 770 and a stop loss at Rs 745 from entry point.

Shares of Wockhardt tanked over 11 per cent on the Bombay Stock Exchange, a day after the company said it would undertake a corporate debt ...

Wockhardt chairman and managing director Habil Khorakiwala’s move to step down from the post of MD and appoint younger son Murtaza Khorakiw...

Pharmaceutical firm Wockhardt on Tuesday said it will shortly launch Azithromycin tablets, which are used for treating different kinds of i...

Pharma company Wockhardt Ltd on Wednesday said it has received US Food and Drug Administration (USFDA) approval for Cefprozil tablets, an a...

Pharmaceutical and biotechnology major Wockhardt signed a memorandum of understanding (MoU) with Maharashtra Industrial Development Corpora...